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Who developed these recommendations?
The American College of Physicians (ACP) developed these recommendations. The ACP is a professional organization for internal medicine doctors, who specialize in health care for adults.
What is the problem and what is known about it so far?
Type 2 diabetes is a common disease that makes it difficult for the body to use sugar and store energy from food. Common symptoms include urinating often and increased thirst, but diabetes often has no symptoms. Over time, high blood sugar levels can lead to health problems, including blindness, kidney failure, nerve damage, heart attack, stroke, and the need to amputate certain body parts (such as fingers and toes). Treatment to control blood sugar levels includes eating healthy food, regular exercise, and medicines. Doctors measure sugar with a blood test called hemoglobin A 1c (HbA 1c ) to diagnose and control the disease. Different organizations define good control with different HbA 1c levels. The ACP reviewed guidelines for HbA 1c targets in nonpregnant adults with type 2 diabetes to develop guidance to help doctors and patients decide what levels to aim for.
How did the ACP develop these recommendations?
The ACP Clinical Guidelines Committee reviewed 6 guidelines to rate their quality. They used this information to develop recommendations for HbA 1c targets that ACP believes would be best for nonpregnant adults with type 2 diabetes. An HbA 1c level below 7% can reduce the chances of diabetes complications. However, this level can be difficult to achieve and can be associated with weight gain and life-threatening episodes of low blood sugar.
What does the ACP suggest that patients and doctors do? Doctors and patients should work together to create goals for diabetes control. These goals should consider the benefits and harms of diabetes medicines, patient preferences and general health, and costs of treatment.
For most patients, HbA 1c levels should be between 7% and 8%. Doctors and patients should consider decreasing the dose or stopping diabetes medicines if HbA 1c levels fall below 6.5%.
If a patient has type 2 diabetes and is not expected to live longer than 10 years, lower HbA 1c levels might cause more harm than benefit. These patients include people older than 80 years; people who live in a nursing home; and people who have serious health conditions, such as dementia, cancer, kidney disease, severe chronic obstructive pulmonary disease, or heart failure. 
Questions you may want to ask your doctor

